The Cerebroplacental–Renal Ratio as a Novel Doppler-Based Marker of Adverse Perinatal Outcome in Pregnancy-Induced Hypertension
Abstract
Share and Cite
Kaya, Y.; Bilirer, K.K.; Batman, A.; Çiçek, B.; Yaman, İ.; Yeniocak, A.S.; Tercan, C.; Ohanoglu Cetinel, K.; Kaya, D.Y.Y.; Polat, G. The Cerebroplacental–Renal Ratio as a Novel Doppler-Based Marker of Adverse Perinatal Outcome in Pregnancy-Induced Hypertension. Medicina 2026, 62, 1806. https://doi.org/10.3390/medicina62091806
Kaya Y, Bilirer KK, Batman A, Çiçek B, Yaman İ, Yeniocak AS, Tercan C, Ohanoglu Cetinel K, Kaya DYY, Polat G. The Cerebroplacental–Renal Ratio as a Novel Doppler-Based Marker of Adverse Perinatal Outcome in Pregnancy-Induced Hypertension. Medicina. 2026; 62(9):1806. https://doi.org/10.3390/medicina62091806
Chicago/Turabian StyleKaya, Yücel, Kübra Kurt Bilirer, Aybekcan Batman, Burcu Çiçek, İlteriş Yaman, Ali Selçuk Yeniocak, Can Tercan, Karolin Ohanoglu Cetinel, Damla Yasemin Yenliç Kaya, and Gülseren Polat. 2026. "The Cerebroplacental–Renal Ratio as a Novel Doppler-Based Marker of Adverse Perinatal Outcome in Pregnancy-Induced Hypertension" Medicina 62, no. 9: 1806. https://doi.org/10.3390/medicina62091806
APA StyleKaya, Y., Bilirer, K. K., Batman, A., Çiçek, B., Yaman, İ., Yeniocak, A. S., Tercan, C., Ohanoglu Cetinel, K., Kaya, D. Y. Y., & Polat, G. (2026). The Cerebroplacental–Renal Ratio as a Novel Doppler-Based Marker of Adverse Perinatal Outcome in Pregnancy-Induced Hypertension. Medicina, 62(9), 1806. https://doi.org/10.3390/medicina62091806

